Improving Quality of Care for the Dying Patient in Hospice: A Quasi Experimental Trial in Liguria Region

NCT ID: NCT01470625

Last Updated: 2013-01-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

282 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-09-30

Study Completion Date

2012-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a before-after phase II study, according to the Medical Research Council framework, investigating the feasibility of introducing the Liverpool Care Pathway for the dying patient (LCP) in 5 Ligurian hospices.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

End-of-Life

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LCP Program

The LCP Program is continuous quality improvement program of end-of-life care implemented in hospice

Group Type OTHER

LCP Program

Intervention Type OTHER

The LCP Program is continuous quality improvement program of end-of-life care implemented in hospice

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LCP Program

The LCP Program is continuous quality improvement program of end-of-life care implemented in hospice

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patients deceased in the hospice during the evaluation period
* Approval of ethics committee

Exclusion Criteria

* Prior use of LCP in the hospice
* Deceased was a relative of a hospice member of staff
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Regional Palliative Care Network

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Massimo Costantini

Role: STUDY_CHAIR

IRCCS AOU San Martino- IST

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospice ASL 4

Chiavari, Genova, Italy

Site Status

Hospice Gigi Ghirotti "Albaro"

Genova, , Italy

Site Status

Hospice Gigi Ghirotti "Bolzaneto"

Genova, , Italy

Site Status

Hospice ASL1 Liguria

Imperia, , Italy

Site Status

CENTRO MISERICORDIA" SANTA M.G.ROSSELLO. Ist.Figlie Ns Signora Misericordia

Savona, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LCP-I LIG

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Advanced Dementia and End-of-life
NCT03548142 COMPLETED NA
Enhancing Palliative Care in ICU
NCT06605079 RECRUITING NA